Besides the natural history of each genetic subtype of B‐ALL, the Mexican population's genetic background may impact patients' recurrence with the coexistence of CRLF2 abnormalities and recurrent gene fusions [7, 18, 19]. The gene discussed is CRLF2; the disease is acute lymphoblastic leukemia.